Asian Groups Challenge FTAs With U.S. As Anti-Generic Drugs
This article was originally published in PharmAsia News
Executive Summary
U.S. and European Union free trade agreements with several Asian nations are coming under increasing attack by health, medical and patient groups as potential restrictions on the availability of generic drugs.